HEADER HYDROLASE/HYDROLASE INHIBITOR 11-DEC-15 5FAP
TITLE CTX-M-15 IN COMPLEX WITH FPI-1602
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BETA-LACTAMASE;
COMPND 3 CHAIN: B, A;
COMPND 4 EC: 3.5.2.6;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI;
SOURCE 3 ORGANISM_TAXID: 562;
SOURCE 4 GENE: BLAUOE-1, BLA, BLA CTX-M-15, BLA_1, BLA_2, BLA_3, BLACTX-M-15,
SOURCE 5 BLACTX-M15, CTX-M-15, ECONIH1_02760, ECONIH1_27135, ERS085368_04262,
SOURCE 6 ERS085370_01802, ERS085377_05268, ERS139214_01914, ERS139238_04648,
SOURCE 7 ERS139238_04652, ERS150880_04508, HUS2011_PI0012, PCTXM15_EC8_00003,
SOURCE 8 SK84_05077, SK86_03319;
SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.M.KING,D.T.KING,S.FRENCH,E.BROUILLETTE,A.ASLI,A.N.ALEXANDER,
AUTHOR 2 M.VUCKOVIC,S.N.MAITI,T.R.PARR,E.D.BROWN,F.MALOUIN,N.C.J.STRYNADKA,
AUTHOR 3 G.D.WRIGHT
REVDAT 6 09-OCT-24 5FAP 1 REMARK
REVDAT 5 27-SEP-23 5FAP 1 REMARK
REVDAT 4 20-NOV-19 5FAP 1 REMARK
REVDAT 3 20-SEP-17 5FAP 1 REMARK
REVDAT 2 27-APR-16 5FAP 1 JRNL
REVDAT 1 20-JAN-16 5FAP 0
JRNL AUTH A.M.KING,D.T.KING,S.FRENCH,E.BROUILLETTE,A.ASLI,
JRNL AUTH 2 J.A.ALEXANDER,M.VUCKOVIC,S.N.MAITI,T.R.PARR,E.D.BROWN,
JRNL AUTH 3 F.MALOUIN,N.C.STRYNADKA,G.D.WRIGHT
JRNL TITL STRUCTURAL AND KINETIC CHARACTERIZATION OF
JRNL TITL 2 DIAZABICYCLOOCTANES AS DUAL INHIBITORS OF BOTH
JRNL TITL 3 SERINE-BETA-LACTAMASES AND PENICILLIN-BINDING PROTEINS.
JRNL REF ACS CHEM.BIOL. V. 11 864 2016
JRNL REFN ESSN 1554-8937
JRNL PMID 26731698
JRNL DOI 10.1021/ACSCHEMBIO.5B00944
REMARK 2
REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0071
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.97
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3
REMARK 3 NUMBER OF REFLECTIONS : 13713
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.189
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.227
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300
REMARK 3 FREE R VALUE TEST SET COUNT : 761
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77
REMARK 3 REFLECTION IN BIN (WORKING SET) : 964
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.25
REMARK 3 BIN R VALUE (WORKING SET) : 0.2700
REMARK 3 BIN FREE R VALUE SET COUNT : 59
REMARK 3 BIN FREE R VALUE : 0.3380
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3878
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 48
REMARK 3 SOLVENT ATOMS : 85
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.48
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.36000
REMARK 3 B22 (A**2) : 0.46000
REMARK 3 B33 (A**2) : -0.15000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.13000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.343
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3986 ; 0.010 ; 0.019
REMARK 3 BOND LENGTHS OTHERS (A): 3884 ; 0.000 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5410 ; 1.256 ; 1.974
REMARK 3 BOND ANGLES OTHERS (DEGREES): 8924 ; 3.879 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 5.694 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 162 ;42.442 ;24.568
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 676 ;16.674 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;16.048 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 636 ; 0.092 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4550 ; 0.013 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 848 ; 0.010 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2068 ; 2.040 ; 2.608
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2067 ; 2.041 ; 2.608
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2578 ; 3.182 ; 3.909
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2579 ; 3.181 ; 3.909
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1918 ; 2.674 ; 2.907
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1919 ; 2.673 ; 2.907
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2829 ; 4.297 ; 4.241
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4126 ; 5.487 ;20.298
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4122 ; 5.486 ;20.302
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 5FAP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-15.
REMARK 100 THE DEPOSITION ID IS D_1000216268.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-JUL-14
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : CLSI
REMARK 200 BEAMLINE : 08ID-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14478
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700
REMARK 200 RESOLUTION RANGE LOW (A) : 30.970
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4
REMARK 200 DATA REDUNDANCY : 2.500
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 4HBT
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.81
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.1M MES PH6.5,
REMARK 280 30% PEG5K MONOMETHYL ETHER, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.91500
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLN B 26
REMARK 465 THR B 27
REMARK 465 ALA B 28
REMARK 465 GLY B 287
REMARK 465 LEU B 288
REMARK 465 GLN A 26
REMARK 465 THR A 27
REMARK 465 ALA A 28
REMARK 465 GLY A 287
REMARK 465 LEU A 288
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OG SER B 70 CAM 602 B 301 1.01
REMARK 500 OG SER B 70 OAN 602 B 301 1.83
REMARK 500 OG SER B 70 N 602 B 301 2.11
REMARK 500 CB SER A 70 CAM 602 A 301 2.13
REMARK 500 OG SER A 70 N 602 A 301 2.14
REMARK 500 OG SER A 70 OAN 602 A 301 2.19
REMARK 500 CB SER B 70 CAM 602 B 301 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 CYS B 69 -139.15 60.56
REMARK 500 SER B 220 -117.20 -104.43
REMARK 500 CYS A 69 -132.60 60.83
REMARK 500 ASN A 89 31.82 -99.51
REMARK 500 VAL A 103 -144.51 -132.20
REMARK 500 ASN A 106 63.60 -150.53
REMARK 500 SER A 220 -117.27 -101.02
REMARK 500 ASP A 245 125.81 -171.13
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 GLU B 87 PRO B 88 -148.26
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 602 B 301
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5FAO RELATED DB: PDB
REMARK 900 RELATED ID: 5FA7 RELATED DB: PDB
REMARK 900 RELATED ID: 5FAQ RELATED DB: PDB
REMARK 900 RELATED ID: 5FAS RELATED DB: PDB
REMARK 900 RELATED ID: 5FAT RELATED DB: PDB
DBREF 5FAP B 26 288 UNP Q9EXV5 Q9EXV5_ECOLX 29 291
DBREF 5FAP A 26 288 UNP Q9EXV5 Q9EXV5_ECOLX 29 291
SEQRES 1 B 263 GLN THR ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU
SEQRES 2 B 263 ARG GLN SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN
SEQRES 3 B 263 THR ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU
SEQRES 4 B 263 ARG PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA
SEQRES 5 B 263 ALA ALA VAL LEU LYS LYS SER GLU SER GLU PRO ASN LEU
SEQRES 6 B 263 LEU ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL
SEQRES 7 B 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR
SEQRES 8 B 263 MET SER LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR
SEQRES 9 B 263 SER ASP ASN VAL ALA MET ASN LYS LEU ILE ALA HIS VAL
SEQRES 10 B 263 GLY GLY PRO ALA SER VAL THR ALA PHE ALA ARG GLN LEU
SEQRES 11 B 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR
SEQRES 12 B 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR
SEQRES 13 B 263 SER PRO ARG ALA MET ALA GLN THR LEU ARG ASN LEU THR
SEQRES 14 B 263 LEU GLY LYS ALA LEU GLY ASP SER GLN ARG ALA GLN LEU
SEQRES 15 B 263 VAL THR TRP MET LYS GLY ASN THR THR GLY ALA ALA SER
SEQRES 16 B 263 ILE GLN ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP
SEQRES 17 B 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE
SEQRES 18 B 263 ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU
SEQRES 19 B 263 VAL THR TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER
SEQRES 20 B 263 ARG ARG ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR
SEQRES 21 B 263 ASP GLY LEU
SEQRES 1 A 263 GLN THR ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU
SEQRES 2 A 263 ARG GLN SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN
SEQRES 3 A 263 THR ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU
SEQRES 4 A 263 ARG PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA
SEQRES 5 A 263 ALA ALA VAL LEU LYS LYS SER GLU SER GLU PRO ASN LEU
SEQRES 6 A 263 LEU ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL
SEQRES 7 A 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR
SEQRES 8 A 263 MET SER LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR
SEQRES 9 A 263 SER ASP ASN VAL ALA MET ASN LYS LEU ILE ALA HIS VAL
SEQRES 10 A 263 GLY GLY PRO ALA SER VAL THR ALA PHE ALA ARG GLN LEU
SEQRES 11 A 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR
SEQRES 12 A 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR
SEQRES 13 A 263 SER PRO ARG ALA MET ALA GLN THR LEU ARG ASN LEU THR
SEQRES 14 A 263 LEU GLY LYS ALA LEU GLY ASP SER GLN ARG ALA GLN LEU
SEQRES 15 A 263 VAL THR TRP MET LYS GLY ASN THR THR GLY ALA ALA SER
SEQRES 16 A 263 ILE GLN ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP
SEQRES 17 A 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE
SEQRES 18 A 263 ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU
SEQRES 19 A 263 VAL THR TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER
SEQRES 20 A 263 ARG ARG ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR
SEQRES 21 A 263 ASP GLY LEU
HET 602 B 301 24
HET 602 A 301 24
HETNAM 602 [[(3~{R},6~{S})-6-[(AZETIDIN-3-YLCARBONYLAMINO)
HETNAM 2 602 CARBAMOYL]-1-METHANOYL-PIPERIDIN-3-YL]AMINO] HYDROGEN
HETNAM 3 602 SULFATE
FORMUL 3 602 2(C11 H19 N5 O7 S)
FORMUL 5 HOH *85(H2 O)
HELIX 1 AA1 ASP B 29 GLY B 42 1 14
HELIX 2 AA2 CYS B 69 THR B 71 5 3
HELIX 3 AA3 SER B 72 GLU B 87 1 16
HELIX 4 AA4 ASN B 89 ASN B 92 5 4
HELIX 5 AA5 LYS B 98 LEU B 102 5 5
HELIX 6 AA6 ILE B 108 HIS B 112 5 5
HELIX 7 AA7 LEU B 119 TYR B 129 1 11
HELIX 8 AA8 ASP B 131 GLY B 143 1 13
HELIX 9 AA9 GLY B 144 GLY B 156 1 13
HELIX 10 AB1 PRO B 167 THR B 171 5 5
HELIX 11 AB2 SER B 182 LEU B 195 1 14
HELIX 12 AB3 GLY B 200 GLY B 213 1 14
HELIX 13 AB4 SER B 220 LEU B 225 5 6
HELIX 14 AB5 GLY B 239 GLY B 241 5 3
HELIX 15 AB6 ARG B 273 ASP B 286 1 14
HELIX 16 AB7 VAL A 30 GLY A 42 1 13
HELIX 17 AB8 CYS A 69 THR A 71 5 3
HELIX 18 AB9 SER A 72 SER A 84 1 13
HELIX 19 AC1 GLU A 85 SER A 86 5 2
HELIX 20 AC2 GLU A 87 LEU A 91 5 5
HELIX 21 AC3 ILE A 108 VAL A 113 5 6
HELIX 22 AC4 LEU A 119 TYR A 129 1 11
HELIX 23 AC5 ASP A 131 GLY A 143 1 13
HELIX 24 AC6 GLY A 144 LEU A 155 1 12
HELIX 25 AC7 PRO A 167 THR A 171 5 5
HELIX 26 AC8 SER A 182 LEU A 195 1 14
HELIX 27 AC9 GLY A 200 GLY A 213 1 14
HELIX 28 AD1 ILE A 221 LEU A 225 5 5
HELIX 29 AD2 GLY A 239 GLY A 241 5 3
HELIX 30 AD3 ARG A 273 ASP A 286 1 14
SHEET 1 AA1 5 GLN B 57 TYR B 60 0
SHEET 2 AA1 5 ARG B 44 ASN B 51 -1 N VAL B 47 O TYR B 60
SHEET 3 AA1 5 LEU B 257 THR B 264 -1 O TYR B 262 N GLY B 46
SHEET 4 AA1 5 THR B 242 TRP B 250 -1 N ALA B 247 O LEU B 259
SHEET 5 AA1 5 VAL B 230 GLY B 238 -1 N GLY B 236 O ASN B 244
SHEET 1 AA2 2 PHE B 66 ALA B 67 0
SHEET 2 AA2 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66
SHEET 1 AA3 2 ARG B 94 GLU B 96 0
SHEET 2 AA3 2 THR B 116 SER B 118 -1 O MET B 117 N VAL B 95
SHEET 1 AA4 5 GLN A 57 TYR A 60 0
SHEET 2 AA4 5 ARG A 44 ASN A 51 -1 N VAL A 47 O TYR A 60
SHEET 3 AA4 5 LEU A 257 THR A 264 -1 O TYR A 262 N GLY A 46
SHEET 4 AA4 5 THR A 243 TRP A 250 -1 N ILE A 249 O LEU A 257
SHEET 5 AA4 5 VAL A 230 SER A 237 -1 N VAL A 230 O TRP A 250
SHEET 1 AA5 2 PHE A 66 ALA A 67 0
SHEET 2 AA5 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66
SHEET 1 AA6 2 ARG A 94 ILE A 97 0
SHEET 2 AA6 2 GLY A 115 SER A 118 -1 O GLY A 115 N ILE A 97
LINK OG SER A 70 CAM 602 A 301 1555 1555 1.21
CISPEP 1 GLU B 166 PRO B 167 0 1.74
CISPEP 2 GLU A 166 PRO A 167 0 7.20
SITE 1 AC1 9 SER B 70 ASN B 104 SER B 130 ASN B 132
SITE 2 AC1 9 PRO B 167 ASN B 170 THR B 235 GLY B 236
SITE 3 AC1 9 SER B 237
CRYST1 63.120 61.830 73.070 90.00 103.98 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015843 0.000000 0.003944 0.00000
SCALE2 0.000000 0.016173 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014103 0.00000